INTERCEPT PHARMACEUTICALS, INC. Insider Trading for June 2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in INTERCEPT PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in INTERCEPT PHARMACEUTICALS, INC. for June 2015.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 24 2015 | ICPT | INTERCEPT PHARMACE ... | WILLIAMS NICOLE | Director | Option Exercise | M | 9.82 | 974 | 9,567 | 1,082 | |
| Jun 24 2015 | ICPT | INTERCEPT PHARMACE ... | WILLIAMS NICOLE | Director | Sell | S | 265.14 | 974 | 258,246 | 962 | 1.9 K to 962 (-50.31 %) |
| Jun 24 2015 | ICPT | INTERCEPT PHARMACE ... | WILLIAMS NICOLE | Director | Buy | M | 9.82 | 974 | 9,567 | 1,936 | 962 to 1.9 K (+101.25 %) |
| Jun 17 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Option Exercise | M | 8.67 | 3,500 | 30,333 | 26,294 | |
| Jun 17 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 242.05 | 1,900 | 459,896 | 18,514 | 20.4 K to 18.5 K (-9.31 %) |
| Jun 17 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 241.03 | 1,600 | 385,650 | 20,414 | 22 K to 20.4 K (-7.27 %) |
| Jun 17 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Buy | M | 8.67 | 3,500 | 30,333 | 22,014 | 18.5 K to 22 K (+18.90 %) |
| Jun 12 2015 | ICPT | INTERCEPT PHARMACE ... | VEITINGER KLAUS R DR | Director | Option Exercise | M | 21.50 | 391 | 8,407 | 7,972 | |
| Jun 12 2015 | ICPT | INTERCEPT PHARMACE ... | VEITINGER KLAUS R DR | Director | Sell | S | 238.21 | 391 | 93,140 | 2,166 | 2.6 K to 2.2 K (-15.29 %) |
| Jun 12 2015 | ICPT | INTERCEPT PHARMACE ... | VEITINGER KLAUS R DR | Director | Buy | M | 21.50 | 391 | 8,407 | 2,557 | 2.2 K to 2.6 K (+18.05 %) |
| Jun 10 2015 | ICPT | INTERCEPT PHARMACE ... | Adorini Luciano | Chief Scientific Of ... | Option Exercise | M | 8.67 | 4,000 | 34,667 | 67 | |
| Jun 10 2015 | ICPT | INTERCEPT PHARMACE ... | Adorini Luciano | Chief Scientific Of ... | Sell | S | 250.34 | 2,000 | 500,670 | 10,060 | 12.1 K to 10.1 K (-16.58 %) |
| Jun 10 2015 | ICPT | INTERCEPT PHARMACE ... | Adorini Luciano | Chief Scientific Of ... | Sell | S | 246.46 | 2,000 | 492,928 | 12,060 | 14.1 K to 12.1 K (-14.22 %) |
| Jun 10 2015 | ICPT | INTERCEPT PHARMACE ... | Adorini Luciano | Chief Scientific Of ... | Buy | M | 8.67 | 4,000 | 34,667 | 14,060 | 10.1 K to 14.1 K (+39.76 %) |
| Jun 05 2015 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Option Exercise | M | 21.50 | 4,651 | 99,997 | 47,240 | |
| Jun 05 2015 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Option Exercise | M | 8.67 | 1,910 | 16,553 | 34,404 | |
| Jun 05 2015 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Buy | M | 21.50 | 4,651 | 99,997 | 502,304 | 497.7 K to 502.3 K (+0.93 %) |
| Jun 05 2015 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Buy | M | 8.67 | 1,910 | 16,553 | 497,653 | 495.7 K to 497.7 K (+0.39 %) |